# Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adjuvant-paclitaxel-and-trastuzumab-for-node-negative-her2-positive-breast/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sara M. Tolaney,William T. Barry,Chau T. Dang,Denise A. Yardley,Beverly Moy,P. Kelly Marcom,Kathy S. Albain,Hope S. Rugo,Matthew J. Ellis,Iuliana Shapira,Antonio C. Wolff,Lisa A. Carey,Beth Overmoyer,Ann H. Partridge,Hao Guo,Clifford A. Hudis,Ian E. Krop,Harold J. Burstein,Eric P. Winer |
| Citations | 753 |
| DOI | 10.1056/nejmoa1406281 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1406281?articleTools=true |
| OpenAlex ID | https://openalex.org/W2095633632 |
| PMID | 25564897 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Clifford A. Hudis](https://scholariq.org/researchers/clifford-a-hudis/)
- [Lisa A. Carey](https://scholariq.org/researchers/lisa-a-carey/)
- [Ann H. Partridge](https://scholariq.org/researchers/ann-h-partridge/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.